Characteristics of hemodialysis patient with critical COVID ‐19

Abstract : Patient with chronical diease such as Hemodialysis more likely need psycotherapy because until now medical atention only focus on physical aspect. Psycotherapy that can be used on Hemodialysis that going through depression is cognitive therapy and logo therapy. This study was to analysed the difference of influence between cognitive therapy and logo therapy on Hemodialysis patient that going through depression. This study was used quasi experimental pre–post test design. Respondent taking part in this study was 15 respondent for cognitive therapy and 15 respondent for logo therapy with puporsive sampling procedure. Study was conducted on Hemodialysis unit on RS Wava Husada Kepanjen from 21 April until 26 Mey 2017. Data analysis used on this study was dependent t test and independent t test. Dependent t test analysis showed significant value is 0,000 (less than < 0,05).Analysis showed significant value is 0,000 (less than < 0,05) that means there is difference between cognitive therapy and logo therapy to decrease depression on hemodialysis patient with mean value cognitive therapy (1,62) dan logo therapy (3,82). Conclussion on this study is that logo therapy more effective to reduce depression on Hemodialysis patient than cognitive therapy so logo therapy can applicated in hemodialysis patient.Keyword : cognitive therapy, logo therapy, depression in hemodialysis patient Abstrak : Pasien dengan penyakit kronis dengan hemodialisis diperlukan psikoterapi karena selama ini fokus penanganan di pelayanan kesehatan hanya pada masalah fisik. Psikoterapi yang bisa digunakan pada pasien hemodialisis yang mengalami depresi adalah cognitive therapy dan logo therapy. Penelitian ini bertujuan untuk menganalisis perbedaan pengaruh cognitive therapy dan logo therapy terhadap depresi pada pasien dengan hemodialisis. Penelitian ini menggunakan desain penelitian quasi experimental pre – post test design. Jumlah responden dalam penelitian ini 15 responden untuk kelompok cognitive therapy dan 15 responden untuk kelompok logo therapy yang didapatkan dengan menggunakan tehnik purposive sampling. Penelitian dilakukan di unit hemodialisis RS Wava Husada Kepanjen mulai tanggal 21 April – 26 Mei 2017. Pemberian terapi dilakukan oleh peneliti sendiri yang telah mendapatkan lisensi dari perawat spesialis jiwa. Analisis data yang digunakan dalam penelitian ini adalah dependent t test dan independent t test. Hasil analisis dependent t test pada kelompok sebelum dan setelah diberikan cognitive therapy dan logo therapy didapatkan hasil nilai signifikansi 0,000 < 0,05 yang berarti bahwa ada perbedaan skor depresi antara sebelum dan sesudah diberikan pemberian cognitive therapy dan logo therapy Sedangkan hasil analisis independent t test menunjukkan bahwa nilai signifikansi 0,000 < 0,05 yang berarti ada perbedaan yang bermakna antara cognitive therapy dan logo therapy dalam menurunkan depresi pada pasien dengan hemodialisis yaitu dengan rata – rata penurunan terhadap depresi untuk cognitive therapy dan logo therapy masing – masing yaitu 1,62 dan 3,86. Hal ini berarti bahwa logo therapy lebih efektif menurunkan depresi pada pasien hemodialisis dari pada cognitive therapy. Berdasarkan hasil penelitian tersebut diharapkan bahwa logo therapy bisa diaplikasikan sebagai alternatif psikoterapi pada pasien hemodialisis.Kata Kunci: cognitive therapy, logo therapy, depresi pada pasien hemodialisis

Download Full-text

Brachiocephalic Vein Occlusion in a Hemodialysis Patient

American Journal of Nephrology ◽

10.1159/000167976 ◽

1989 ◽

Vol 9 (3) ◽

pp. 261-262 ◽

Cited By ~ 4

Author(s):

Alfred K. Cheung ◽

Richard Brownley

Keyword(s):

Hemodialysis Patient ◽

Brachiocephalic Vein ◽

Vein Occlusion

Download Full-text

A hemodialysis patient with difficulty ambulating: Answers

Pediatric Nephrology ◽

10.1007/s00467-021-04931-1 ◽

2021 ◽

Author(s):

Nina Mann ◽

Annemarie Fayemi ◽

Melissa Myles ◽

Nicole Kelley ◽

Brian Carmine ◽

...

Keyword(s):

Hemodialysis Patient

Download Full-text

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient

Case Reports in Nephrology and Dialysis ◽

10.1159/000512612 ◽

2021 ◽

pp. 167-175

Author(s):

Stephanie Munie ◽

Pairach Pintavorn

Keyword(s):

Copper Deficiency ◽

Hemodialysis Patient ◽

Esrd Patient ◽

Serological Testing ◽

Zinc Supplement ◽

Excessive Intake ◽

Stage Renal Disease ◽

End Stage ◽

Work Up ◽

Excess Zinc

Excessive intake of zinc is a known but often forgotten cause of copper deficiency, and its consequences in the context of end-stage renal disease (ESRD) are not widely discussed. Zinc-induced copper deficiency (ZICD) can result in erythropoietin (EPO)-resistant anemia and may not be considered as a possible etiology when conducting the work-up. We present a case wherein an ESRD patient had been receiving excess zinc for several months and subsequently experienced EPO-resistant anemia. Our patient’s GI work-up was negative, and increased doses of iron and EPO-stimulating agent were ineffective. She underwent a bone marrow biopsy and more serological testing. She was ultimately diagnosed with ZICD, and cessation of her zinc supplement and initiation of copper replacement proved effective in restoring EPO responsiveness. Awareness of ZICD as a possible factor in EPO-resistant anemia could lead to an expedited diagnosis and avoid an unnecessary and extensive work-up.

Download Full-text

Thrombocytopenia and Anemia Induced by Niceritrol Used for Amelioration of Hyperphosphatemia in a Hemodialysis Patient

Nephron ◽

10.1159/000045722 ◽

2000 ◽

Vol 86 (1) ◽

pp. 96-98 ◽

Cited By ~ 7

Author(s):

Hiroko Wakasugi ◽

Takahiro Futami ◽

Eri Muso ◽

Takahiko Ono ◽

Shigetake Sasayama ◽

...

Keyword(s):

Hemodialysis Patient

Download Full-text

Recurrent thrombosis of an arteriovenous fistula as a complication of COVID-19 in a chronic hemodialysis patient: A case report

The Journal of Vascular Access ◽

10.1177/11297298211000881 ◽

2021 ◽

pp. 112972982110008

Author(s):

Joao Pedro Teixeira ◽

Sara A Combs ◽

Jonathan G Owen

Keyword(s):

Arteriovenous Fistula ◽

Hemodialysis Patient ◽

Blood Stream Infection ◽

Blood Stream ◽

Chronic Hemodialysis ◽

Risk Of Death ◽

Catheter Directed Thrombolysis ◽

Intravenous Heparin ◽

Increased Risk ◽

End Stage

Patients with end-stage kidney disease are at increased risk of death from coronavirus disease 2019 (COVID-19). In addition, severe COVID-19 has been associated with an increased risk of arterial and venous thromboses. In this report, we describe the case of a hemodialysis patient who developed an otherwise-unexplained thrombosis of an arteriovenous fistula during a symptomatic COVID-19 infection. Despite prompt treatment with three technically successful thrombectomies along with systemic intravenous heparin and two rounds of catheter-directed thrombolysis with tissue plasminogen activator, the fistula rapidly re-thrombosed each time and he required tunneled dialysis catheter placement. He subsequently required admission for hypoxemia from COVID-19 pneumonia and ultimately developed a catheter-related blood stream infection that likely contributed to his death. As the fistula had been previously well functioning and no angiographic explanation for the thrombosis was found, we speculate in this case the recurrent thromboses were related to the hypercoagulable state characteristic of severe COVID-19. Interventionalists performing hemodialysis access procedures should be aware of the prothrombotic state associated with COVID-19 and should consider it when deliberating how to best plan and approach access interventions in patients with symptomatic COVID-19.

Download Full-text

Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases

Pharmacy ◽

10.3390/pharmacy8020059 ◽

2020 ◽

Vol 8 (2) ◽

pp. 59

Author(s):

Soo Min Jang ◽

Smitha Anam ◽

Tara Pringle ◽

Paul Lahren ◽

Sergio Infante

Keyword(s):

Calcium Release ◽

Hemodialysis Patient ◽

Compensatory Mechanism ◽

Normal Range ◽

Mineral And Bone Disorder ◽

Bone Disorder ◽

Stage Renal Disease ◽

End Stage ◽

Esrd Patients ◽

Pth Level

A common complication of end-stage renal disease (ESRD) is mineral and bone disorder. Yet, many anti-osteoporotic drugs are contraindicated in ESRD patients. Denosumab, a monoclonal antibody, does not require renal dose adjustment. However, its use is uncertain due to a lack of safety and efficacy of data in this population. Two hemodialysis patient cases of contrasting responses in parathyroid hormone (PTH) after denosumab administration were observed. Patient 1, a 62-years-old male received denosumab 60 mg at Day 0. His calcium decreased from 8.8 mg/dL to 6.8 mg/dL on Day 30. The PTH level increased from 265 pg/mL to 372 pg/mL after 30 days. Calcium and PTH levels approached normal range after increasing doses of vitamin D/calcium supplements, and calcitriol. Patient 2, a 72-years-old male on hemodialysis also received denosumab 60 mg on Day 0. His baseline calcium and PTH were 9.2 mg/dL and 420 pg/mL, respectively. On Day 30, his calcium level decreased (6.8 mg/dL) but, PTH level drastically increased (>5000 pg/mL). Denosumab commonly causes hypocalcemia and hyperparathyroidism since it inhibits osteoclast activation, reduces calcium release from bone and increases PTH levels as a compensatory mechanism. With a wait-and-watch approach, Patient 2’s levels approached the normal range (calcium 9.6 mg/dL and PTH 274 pg/mL at Day 90).

Download Full-text

Coronavirus Disease 2019 in a Hemodialysis Patient

Blood Purification ◽

10.1159/000507877 ◽

2020 ◽

Vol 49 (6) ◽

pp. 761-764 ◽

Cited By ~ 1

Author(s):

Hai Yuan ◽

E. Guo ◽

Zhao Gao ◽

Fengqi Hu ◽

Li Lu

Keyword(s):

Mechanical Ventilation ◽

Polymerase Chain Reaction ◽

Hemodialysis Patient ◽

Multiple Organ ◽

Lung Imaging ◽

Maintenance Hemodialysis ◽

Multiple Organ Dysfunction ◽

Chain Reaction ◽

Pharyngeal Swab ◽

Polymerase Chain

There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient’s symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report.

Download Full-text